SVA · NASDAQ
Sinovac Biotech (SVA) Stock Price & Fundamentals
Sinovac Biotech (SVA) closed at $180.94 on Oct 9, 2026, down 0.90% from the previous close of $182.59.
Share price, past year
1Y +3.32%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $180.94 |
| Sep 30, 2026 | $180.75 |
| Aug 31, 2026 | $170.25 |
| Jul 31, 2026 | $180.65 |
| Jun 30, 2026 | $178.09 |
| May 29, 2026 | $181.50 |
| Apr 30, 2026 | $177.59 |
| Mar 31, 2026 | $164.46 |
| Feb 27, 2026 | $166.19 |
| Jan 30, 2026 | $171.81 |
| Dec 31, 2025 | $174.38 |
| Nov 28, 2025 | $177.35 |
| Oct 31, 2025 | $172.30 |
Key statistics
- Market cap
- $13.00B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 71.9M
- Dividend yield
- —
- 52-week range
- $164.39 – $186.84
Sinovac Biotech's market cap is $13.00B, based on a share price of $180.94 and 71.9M shares outstanding as of Dec 31, 2025.
Financials
Sinovac Biotech reported revenue of $386.01M for fiscal 2025, up 6.82% from fiscal 2024.
Sinovac Biotech reported a net loss of $13.49M in fiscal 2023.
Sinovac Biotech's fiscal 2023 net loss was its first in at least 7 years.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $386.01M | +6.8% | — | — | −$0.83 | −$561.10M |
| FY2024ended Dec 31, 2024 | $361.37M | −23.1% | — | — | $1.27 | −$152.85M |
| FY2023ended Dec 31, 2023 | $470.17M | −68.1% | −$13.49M | −2.9% | −$0.19 | −$17.52M |
| FY2022ended Dec 31, 2022 | $1.47B | −92.4% | $14.47M | 1.0% | $0.20 | −$1.11B |
| FY2021ended Dec 31, 2021 | $19.37B | +3,692.5% | $8.12B | 41.9% | $113.44 | $14.73B |
| FY2020ended Dec 31, 2020 | $510.62M | +107.5% | $110.37M | 21.6% | $0.97 | $351.82M |
| FY2019ended Dec 31, 2019 | $246.05M | +7.1% | $44.93M | 18.3% | $0.41 | $28.45M |
| FY2018ended Dec 31, 2018 | $229.65M | +31.7% | $21.78M | 9.5% | $0.34 | $2.33M |
| FY2017ended Dec 31, 2017 | $174.35M | +140.7% | $25.81M | 14.8% | $0.45 | $47.84M |
| FY2016ended Dec 31, 2016 | $72.43M | — | −$596.00K | −0.8% | −$0.01 | −$26.56M |
Company profile
- Name
- Sinovac Biotech, Ltd.
- Ticker
- SVA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- No. 39 Shangdi Xi Road, Haidian District, Beijing, 100085
- Incorporated in
- B9
- Fiscal year ends
- December
- SEC CIK
- 0001084201
Recent SEC filings
- Oct 26, 2000
Frequently asked questions
What is Sinovac Biotech's stock price?
Sinovac Biotech (SVA) closed at $180.94 on Oct 9, 2026, down 0.90% from the previous close of $182.59.
What is Sinovac Biotech's market cap?
Sinovac Biotech's market cap is $13.00B, based on a share price of $180.94 and 71.9M shares outstanding as of Dec 31, 2025.
How much revenue does Sinovac Biotech make?
Sinovac Biotech reported revenue of $386.01M for fiscal 2025, up 6.82% from fiscal 2024.
Sources and methodology
Fundamentals come from Sinovac Biotech, Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures